These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1465 related articles for article (PubMed ID: 28263795)
1. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
3. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer. Ahmed AR; Elkharraz K; Irfan M; Bodmeier R Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130 [TBL] [Abstract][Full Text] [Related]
4. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
5. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method. Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287 [TBL] [Abstract][Full Text] [Related]
6. Microparticles produced by the hydrogel template method for sustained drug delivery. Lu Y; Sturek M; Park K Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903 [TBL] [Abstract][Full Text] [Related]
7. Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres. Ito F; Fujimori H; Makino K Colloids Surf B Biointerfaces; 2008 Jan; 61(1):25-9. PubMed ID: 17719753 [TBL] [Abstract][Full Text] [Related]
8. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Blanco D; Alonso MJ Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods. Zhang XQ; Intra J; Salem AK J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727 [TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
11. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
12. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro]. Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137 [TBL] [Abstract][Full Text] [Related]
13. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589 [TBL] [Abstract][Full Text] [Related]
14. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G; Qiu W; DeLuca PP Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968 [TBL] [Abstract][Full Text] [Related]
17. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
19. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. Li X; Xu Y; Chen G; Wei P; Ping Q Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762 [TBL] [Abstract][Full Text] [Related]
20. Ramizol Wright L; Rao S; Thomas N; Boulos RA; Prestidge CA Drug Dev Ind Pharm; 2018 Sep; 44(9):1451-1457. PubMed ID: 29619851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]